Vaishali Pharma – Q1 PAT at Rs.0.23 lacs against Rs.0.59 lacs QoQ

Vaishali Pharma – Standalone Q1 revenue of FY2020-21 stood at Rs.4.10 crore against Rs.18.20 crore QoQ.

Vaishali Pharma: FY20 profit falls to Rs.3.28 lacs against Rs. 71.36 lacs YoY

Vaishali Pharma: FY19-20 revenue dips at Rs.62.25 crore against Rs.77.07 crore YoY.

Vaishali Pharma registered three new products in Nicaragua market

Three New Products of Vaishali Pharma across different dosages received registration in Nicaragua, Central America.

Vaishali Pharma board approves issue bonus in the ratio of 3:5

Vaishali Pharma, Board of Directors have considered and approved to issue bonus shares at the ratio of 3: 5

Vaishali Pharma registered four drugs in Cambodia Market

Four drugs of Vaishali Pharma across different dosages received registration in Cambodia, Asia.

Revenue shrinks at Vaishali Pharma

Vaishali Pharma announced Board of Directors approved audited financial result for the six months and year end on 31st March, 2019.